AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...

For nearly two decades, Stark Insider has run on a Google Cloud VM hosting an Ubuntu server. It’s been our foundation, but ...